Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 17/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 17/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4033718 | 0.90 | MCHR1 (0.64) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL4033722 | 0.90 | MCHR1 (0.64) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL5529101 | 0.89 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL5529106 | 0.89 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL13793942 | 0.89 | MCHR1 (0.57) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL13795109 | 0.88 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL4206251 | 0.88 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL4206247 | 0.88 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL13795289 | 0.87 | MCHR1 (0.56) | MCHR1ADRA2ANPY5RHTR1AADRA1A | |
| SCHEMBL4354006 | 0.87 | MCHR1 (0.59) | MCHR1ADRA2ANPY5RHTR1AADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1611109-A4 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO LTD (JP) | 2009-06-24 | — | — | EP | disclosed |
| EP-1611109-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004087680-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-10-14 | — | — | WO | disclosed |